Fab dimers of antitumor immunoglobulins as covalent carriers of daunomycin
- PMID: 975021
Fab dimers of antitumor immunoglobulins as covalent carriers of daunomycin
Abstract
Fab dimers were prepared by pepsin digestion from the immunoglobulin fraction of a rabbit antiserum towards the Yac Moloney virus lymphoma cells. Daunomycin was attatched to these (Fab)2 by covalent binding. The resultant conjugates exerted pharmacological toxic activity and specificity towards Yac target cells similar to that observed previously with conjugates of intact anti-Yac IgG. The activity was manifested both in vitro by inhibition of RNA synthesis and by the effect of reduction of the growth of the tumor cells in vivo after short exposure to the conjugates. The potential advantage of using an IgG molecule devoid of its Fc portion is discussed.
Similar articles
-
The specific cytotoxic effects of daunomycin conjugated to antitumor antibodies.Cancer Res. 1975 May;35(5):1182-6. Cancer Res. 1975. PMID: 164280
-
The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities.Cancer Res. 1975 May;35(5):1175-81. Cancer Res. 1975. PMID: 164279
-
Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.J Immunol. 1983 Sep;131(3):1582-90. J Immunol. 1983. PMID: 6350458
-
Site-directed tumor chemotherapy.Compr Ther. 1978 Apr;4(4):68-73. Compr Ther. 1978. PMID: 348397 Review.
-
In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumor antibodies.Immunol Rev. 1982;62:5-27. doi: 10.1111/j.1600-065x.1982.tb00387.x. Immunol Rev. 1982. PMID: 7042540 Review. No abstract available.
Cited by
-
Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency.Cancers (Basel). 2019 Jan 10;11(1):68. doi: 10.3390/cancers11010068. Cancers (Basel). 2019. PMID: 30634580 Free PMC article. Review.
-
Antibodies as specific carriers for chemotherapeutic agents.Cancer Chemother Pharmacol. 1979;3(1):17-24. doi: 10.1007/BF00254415. Cancer Chemother Pharmacol. 1979. PMID: 394875 Review. No abstract available.
-
Oncostatic-antibody complexes in chemotherapy.Cancer Chemother Pharmacol. 1980;4(1):29-32. doi: 10.1007/BF00255454. Cancer Chemother Pharmacol. 1980. PMID: 6988099 Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources